Genetic Engineering of Co-producing Antigen and the Mucosal Adjuvant 3' 5'- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype
about
Genetic Engineering of Co-producing Antigen and the Mucosal Adjuvant 3' 5'- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype
description
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 04 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Genetic Engineering of Co-prod ...... op a Mucosal Vaccine Prototype
@en
Genetic Engineering of Co-prod ...... lic di Adenosine Monophosphate
@nl
type
label
Genetic Engineering of Co-prod ...... op a Mucosal Vaccine Prototype
@en
Genetic Engineering of Co-prod ...... lic di Adenosine Monophosphate
@nl
prefLabel
Genetic Engineering of Co-prod ...... op a Mucosal Vaccine Prototype
@en
Genetic Engineering of Co-prod ...... lic di Adenosine Monophosphate
@nl
P2093
P2860
P50
P356
P1476
Genetic Engineering of Lactoco ...... op a Mucosal Vaccine Prototype
@en
P2093
Estefanía Prochetto
Florencia B González
Gabriel Cabrera
Ingrid Quintana
Iván Bontempi
Iván Marcipar
Maria F Pacini
Martín Espariz
Silvina R Villar
P2860
P356
10.3389/FMICB.2018.02100
P407
P577
2018-09-04T00:00:00Z